Our company utilizes groundbreaking technology exploiting individual patient data to reprogram human cells combined with artificial intelligence for precision oncology. Our unique system is a powerful technique to amplify ultralow precancerous molecular signals for early detection of carcinogenesis. We utilizes this technology to develop diagnostic tools for detecting solid tumors resolving unmet medical needs. Other mission of our company is to offer to our customers a solution to access to clinical trial in a dish concept. We utilize the personalized cell reprogramming technology to generate on-demand cohorts of patients as well as of healthy individuals for high-fidelity therapeutic efficacy analysis of new compounds in development drug repositioning, and individualized care
